<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lederman, Lynne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Loebel, Antony</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Optimal Dosing of Lurasidone Studied in Acute Schizophrenia</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-08-11 13:08:33</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">6-6</style></pages><abstract><style  face="normal" font="default" size="100%">Lurasidone at a dose of 20 mg per day did not improve responses in patients with acute schizophrenia when compared with placebo; therefore, 40 mg per day appears to be the minimum effective dose. Dose escalation for patients with no response at 2 weeks improved symptoms.</style></abstract><number><style face="normal" font="default" size="100%">11</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>